Information Provided By: 
Fly News Breaks for November 20, 2018
TRHC
Nov 20, 2018 | 08:34 EDT
Baird analyst Matthew Gillmor met with Tabula Rasa Healthcare management, which reinforced his view that the company remains one of the most compelling growth stories in healthcare. The analyst believes its intellectual property is underappreciated by investors but believes that IP, along with its first mover advantage, should drive long-term meaningful upside in the shares. Gillmor reiterated his Outperform rating and $90 price target on Tabula Rasa Healthcare shares.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
